Innovating Works

H2020

Cerrada
HORIZON-EIC-2022-TRANSITIONOPEN-01
EIC Transition Open 2022
Expected Impact:At the end of the EIC Transition project, it should be ready for the next stage, which can be to apply for EIC Accelerator (if you are a SME, including start-ups or spin-offs), to seek other investors or sources of funding, to enter licensing or collaboration agreements with third parties, or other routes to market deployment. In case the project is not led by an SME or commercial partner, the formation and spin out of a new company can be included as part of the activities. It will be expected to describe the intended pathway and route to market in the proposal, and to specify milestones and KPIs during the implementation of your project to assess progress towards the market.
Sólo fondo perdido 100%
Europeo
Mostrando 281 al 300 de 328 resultados
PRESSURO: A life-changing PREssure Sensor System for UROdynamics to solve global urinary storage and voiding p... Innovasjon Norge tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 900 million patients globally suffer from urinary dysfunction. Setting the right diagnosis and deciding upon the right treatment (medication...
2022-10-27 - 2024-10-31 | Financiado
MACOV: Macrophage-based immunotherapy of platinum-resistant ovarian cancer CELLIS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer. About 300,000 women are diagnosed with ovarian ca...
2022-10-27 - 2025-10-31 | Financiado
Mushlabs: Using biotechnology to create the next generation of sustainable foods from the roots of mushrooms MUSHLABS GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Mushlabs is a biotech company that produces meat replacement from mushroom roots called mycelium. We have developed our proprietary fermenta...
2022-10-27 - 2024-10-31 | Financiado
Confident: Confident®, the digital simulation platform that revolutionizes cardiovascular interventions PREDISURGE tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Confident is a disruptive cloud-based platform for digital planning of cardiovascular interventions. Today, many patients do not have access...
2022-10-26 - 2024-10-31 | Financiado
WH2E: Waste Heat to Energy SWEETCH ENERGY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 To cope with the growing global energy consumption and sustainable development scenarios, Waste Heat Recovery is an efficient, green and eco...
2022-10-26 - 2025-11-30 | Financiado
PB_LC: Clinical readiness of a live biotherapeutic for treatment of Non-Small Cell Lung Cancer (NSCLC) PULMOBIOTICS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Non-small-cNon-small-cell carcinomas (NSCLC) represent 80-85% of the worldwide lung cancer cases, which are the leading cause of cancer-rela...
2022-10-26 - 2025-06-30 | Financiado
NARWHAL: A Quantum System on Chip for equal access to secure communications: a pilot-ready photonic integrate... PHOTONIP B.V. tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Quantum computing, forecasted to happen within 10 years, will bring unprecedented computing power, rendering obsolete current data security...
2022-10-26 - 2025-04-30 | Financiado
Codasip RISC-V Solution for High-end Processor IP: Codasip High-end processor IP and high-level design tools for RISC-V CODASIP GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Codasip offers a unique combination of semiconductor processor IP based on the RISC-V open instruction set architecture (ISA) and high-level...
2022-10-26 - 2025-07-31 | Financiado
3DCardiacHTS: Bringing 3D cardiac tissues to high throughput for drug discovery screens RIVER BIOMEDICS B.V. tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 1. Cardiovascular disease is the number 1 cause of death worldwide. Novel cardiovascular drugs have a high failure rate of 91% in clinical t...
2022-10-26 - 2025-11-30 | Financiado
Biventricular Epicardial Augmentation Technology: A revolutionary technology platform for providing life-saving treatment for end-stage heart failure... ADJUCOR GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Over 500K patients in the EU and US suffer from end-stage heart failure (HF), with a life expectancy of <1 year in 38% of cases. The prevale...
2022-10-26 - 2024-12-31 | Financiado
AlkaBurst2.0: AlkaBurst2.0 – A game changing bioreactor for sustainable production of active pharmaceutical ingred... ALKION BIOINNOVATIONS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Alkion, a revolutionary biotech company, is developing a breakthrough biorefinery to produce top quality active pharmaceutical ingredients (...
2022-10-26 - 2024-10-31 | Financiado
Ovavax2: Accelerating scale up and commercialisation of 100% bacteria free eggs for use in production of vacc... OVAGEN GROUP LIMITED tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Ovagen is aiming to transform the egg-based production of vaccines and other biopharmaceutical medicines by producing the world’s first Germ...
2022-10-26 - 2024-10-31 | Financiado
SE€: Unlocking LiDAR technology for European OEMS: For a future of smart and safe Traffic and Mobility XENOMATIX tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Xenomatix is radically innovating the standard operating principle of LiDAR by introducing a light-based 3D measurement system, and is the f...
2022-10-26 - 2024-10-31 | Financiado
Resortecs: Solving the challenge of multi-material garment recycling with thermal disassembly REGENERATION tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Recycling clothes is complicated. Making fabrics new again isn’t the only challenge – threads, zippers and buttons that hold them together a...
2022-10-26 - 2024-08-31 | Financiado
IDEFIX: IDEFIX Multiorgan toxicity and efficacy test platform CHERRY BIOTECH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 To address the critical problem of the failure of animal testing to predict drug effects (toxicity and efficacy) in humans, Cherry Biotech d...
2022-10-26 - 2025-04-30 | Financiado
SolarCO2Value: Lab-to-tech transition of the current best low temperature electrolyser technology for CO2 reduction... ECHEMICLES ZARTKORUEN MUKODO RESZVENYTARSASAG tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 One of the most important challenges of humanity is to maintain economic growth and wellbeing in an environmentally sustainable way. The Eur...
2022-10-26 - 2025-05-31 | Financiado
GEORGIA: GEOtechnical deRisk by Genetic Inverse Analysis SAALG GEOMECHANICS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Mainly funded by taxpayers' money, the construction industry has a poor track record in sustainability, efficiency and safety, which are in...
2022-10-26 - 2024-10-31 | Financiado
ALUVia: Aluminium oxide integrated photonic platform for applications in the ultraviolet (UV) UNIVERSITEIT TWENTE tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 The goal of ALUVia is to establish the first European Al2O3-on-SiO2 (aluminum oxide on silicon dioxide) integrated photonic platform for ope...
2022-10-26 - 2025-11-30 | Financiado
SOILMONITOR: Miniaturized sensor system for continuous soil-nutrient monitoring based on integration of a lab-on-... CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 The soil of the earth is the basis of our life. Efficient use of soil is needed for feeding the growing population. Contaminated soil needs...
2022-10-26 - 2025-10-31 | Financiado
Nanowings: NANOmetric bio-inspired coating for wind turbine WINGS ice protection LINARI ENGINEERING SRL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Although winters are the best season for wind energy harvesting, icing is a major problem affecting the competiveness of this type of renewa...
2022-10-26 - 2025-12-31 | Financiado